Ramazan MEMİŞOĞULLARI, Mehmet TÜRKELİ, Fatih AKÇAY, Ebubekir BAKAN

Effect of Metformin or Gliclazide on Lipid Peroxidation and Antioxidant Levels in Patients with Diabetes Mellitus

Aim: The association between oxidative stress and diabetic complications is well known. The main goal of antidiabetic therapy is to prevent the complications of diabetes. Gliclazide (sulfonylurea) and metformin (biguanide) are two oral antidiabetic drugs that have been proven to prevent diabetic complications. In this study, we aimed to investigate the antioxidant effects of gliclazide or metformin. Materials and Methods: In this study, we evaluated 46 patients with type 2 diabetes mellitus. The patients were divided into three groups according to their treatment modality of gliclazide, metformin, or diet. Erythrocyte glutathione peroxidase (Gpx), glutathione S-transferase (GST), and catalase (CAT) activities and malondialdehyde (MDA) and glutathione (GSH) levels of the patients were measured and compared. Results: The erythrocyte Gpx, GST, and CAT activities were significantly higher, whereas MDA levels were significantly lower in both gliclazide and metformin groups when compared with the diet group. There was no statistically significant difference between gliclazide and metformin groups in terms of activities of antioxidant enzymes and levels of MDA. In addition, GSH levels were not different among the groups. Conclusions: The data obtained in this study showed that gliclazide or metformin administration may decrease oxidative stress, and both drugs had similar effects.

Anahtar Kelimeler:

Diabetes mellitus, gliclazide, metformin, antioxidant enzymes, malondialdehyde

Effect of Metformin or Gliclazide on Lipid Peroxidation and Antioxidant Levels in Patients with Diabetes Mellitus

Keywords:

Diabetes mellitus, gliclazide, metformin, antioxidant enzymes, malondialdehyde,

PDF

___

1. Taysi S, Kocer I, Memisogullari R, Kiziltunc A. Serum oxidant/antioxidant status in patients with Behçet’s disease. Ann Clin Lab Sci 2002; 32: 377-82.
2. Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003; 21: 291–6.
3. Memisogullari R, Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with type 2 diabetes mellitus. J Diabetes Complications 2004; 18: 193– 7.
4. Memisogullari R, Gümüştekin K, Dane Ş, Akçay F. Effect of preinjury supplementation of selenium or vitamin E on lipid peroxidation and antioxidant enzymes in burn injury. Turk J Med Sci 2006; 36: 141-6.
5. Kimoto K, Suzuki K, Kizaki T, Hitomi Y, Ishida H, Katsuta H et al. Gliclazide protects pancreatic b-cells from damage by hydrogen peroxide. Biochem Bioph Res Co 2003; 303: 112–9.
6. Jennings PE, Belch JJ. Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide. Ter Arkh 2001; 73: 27-31.
7. Tessier D, Maheux P, Khalil A, Fulop T. Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes. Metabolism 1999; 48: 897-903.
8. Sliwinska A, Blasiak J, Kasznicki J, Drzewoski J. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM). Chem Biol Interact 2008; 173: 159-65.
9. Formoso G, De Filippis EA, Michetti N, Di Fulvio P, Pandolfi A, Bucciarelli T et al. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects. Diabetes Metab Res Rev 2008; 24: 231-7.
10. Majithiya JB, Balaraman R. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocininduced diabetic rats. Life Sci 2006; 78(22): 2615-24.
11. Iida KT, Kawakami Y, Suzuki M, Shimano H, Toyoshima H, Sone H et al. Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats. Am J Physiol Endocrinol Metab 2003; 284: E1125–E1130.
12. Bonnefont-Rousselot D. Antioxidant and anti-AGE therapeutics: evaluation and perspectives. J Soc Biol 2001; 195: 391-8.
13. Paglia DE, Valentina WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–69.
14. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. Weinheim: Verlag Chemie; 1974. pp. 673–8.
15. Panteghini M, Bais R, van Solinge WW. Methodology, Enzymes. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Philadelphia: WB Saunders; 2006. pp. 1990–2106.
16. Sen CK, Marin E, Kretzschmar M, Hänninen O. Skeletal muscle and liver glutathione homeostasis in response to training, exercise, and immobilization. J Appl Physiol 1992; 73: 1265–72.
17. Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989; 38: 1539–43.
18. Vallejo S, Angulo J, Peiro C, Sanchez-Ferrer A, Cercas E, Llergo JL et al. Prevention of endothelial dysfunction in streptozotocininduced diabetic rats by gliclazide treatment. J Diabetes Complications 2000; 14: 224-33.
19. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59: 365–73.
20. Khouri H, Collin F, Bonnefont-Rousselot D, Legrand A, Jore D, Gardès-Albert M. Radical-induced oxidation of metformin. Eur J Biochem 2004; 271: 4745–52.
21. Alper G, Irer S, Duman E, Çağlayan O, Yılmaz C. Effect of Ideprenyl and gliclazide on oxidant stress/antioxidant status and DNA damage in a diabetic rat model. Endocr Res 2005; 31: 199–212.
22. Pavlovic D, Kocic R, Kocic G, Jevtovic T, Radenkovic S, Mikic D et al. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab 2000; 2: 251-6.